More Healthcare Coverage

  • June 17, 2026

    Doctors Defeat Most Claims In Life Insurance Fraud Dispute

    A life insurer failed to adequately allege that a pair of doctors were knowingly involved in a purported scheme to defraud the carrier into issuing $160 million worth of policies, a New Jersey federal court ruled, tossing all but one claim brought under the state's Insurance Fraud Protection Act.

  • June 16, 2026

    Sanofi Sued Over Qunol CoQ10 'Superior Absorption' Claims

    Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows otherwise and prior legal action that barred it from making similar efficacy claims, alleges a proposed class action filed Monday in New Jersey federal court.

  • June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

  • June 15, 2026

    Fed. Circ. Declines To Revive Medmix's Dentistry Patent

    The Patent Trial and Appeal Board didn't err when invalidating claims of a Medmix Switzerland AG patent used in the dentistry industry, the Federal Circuit said Monday.

  • June 15, 2026

    EEOC Strikes Tentative Deal To End Suit Over Ban On Beards

    The U.S. Equal Employment Opportunity Commission and emergency services provider Global Medical Response told a Colorado federal court they've reached an agreement to resolve the agency's lawsuit alleging that the company's strict no-beard policy violated federal laws.

  • June 15, 2026

    6th Circ. Won't Rehear Home Care OT Exemption Fight

    The Sixth Circuit refused to rehear a home care company's challenge to a U.S. Department of Labor win in an overtime enforcement case, leaving in place a decision that upheld a 2013 rule barring third-party employers from claiming two Fair Labor Standards Act exemptions.

  • June 11, 2026

    Fla. Hospital Antitrust Case Paused For Cert. Denial Appeal

    Patients who have accused hospital operator Health First of illegally fending off competition by preventing doctors from referring patients to rivals have convinced a Florida federal judge to put their lawsuit on hold while they challenge her decision to deny them class certification.

  • June 11, 2026

    5th Circ. Backs $158M Healthcare Fraud Scheme Convictions

    The Fifth Circuit affirmed convictions for two men found guilty in a $158 million healthcare scheme where false claims were submitted for illegitimate compound medications, ruling Wednesday there was sufficient evidence for jurors to find they conspired to defraud federal workers' compensation programs and Blue Cross Blue Shield.

  • June 11, 2026

    Conn. Justices Order New Trial In $13.2M Estate Tax Fight

    The Connecticut Supreme Court on Thursday ordered a new trial over the state's $13.2 million tax assessment against the estate of a health insurance executive who died in Florida, saying a trial judge should have applied a lower standard of proof when determining the executive's state of residence.

  • June 10, 2026

    Estate Says E-Filing Glitch Wrongly Doomed Med Mal Suit

    A Michigan appeals court was urged Wednesday to revive a medical malpractice suit that involves the state's Pandemic Healthcare Immunity Act by counsel for a deceased woman's estate who argued a clerical error kept them from receiving motions for summary judgment in the trial court until it was too late to respond.

  • June 10, 2026

    NJ Hospital Says Ex-CEO's Inaction At Event Supported Firing

    A New Jersey hospital urged a Garden State federal court to reject a bid from its former CEO for a finding that the hospital breached his employment agreement when it fired him over a topless art exhibit at a fundraising event, arguing that the ex-CEO has misinterpreted its sexual harassment policy.

  • June 10, 2026

    NY Judge Says Insurer Owes No Coverage In $1.6M Care Row

    A New York federal judge said an insurer does not have to defend or indemnify a nursing and rehabilitation facility in a hospital's lawsuit seeking to recover $1.6 million in medical expenses for a former worker, finding Tuesday that the underlying action isn't a covered claim.

  • June 10, 2026

    User Says 'Nature's Ozempic' Can't Keep Weight Loss Promise

    A proposed class of supplement buyers is suing the makers of Metabolism Ignite in California federal court, saying the supplements, advertised as "Nature's Ozempic," can't match the effectiveness of the name-brand medication that the advertisers compare it to.

  • June 08, 2026

    AIPLA, NAM Rally Behind Moderna's Fight Over Vax Patents

    The American Intellectual Property Law Association, National Association of Manufacturers and others urged the Federal Circuit to undo a lower court's ruling that Moderna, and not the government, must face a multibillion-dollar patent infringement suit over its COVID-19 vaccine.

  • June 08, 2026

    Ex-Dietary Aide Says Harassment Report Led To Demotion

    A onetime dietary aide at a rehabilitation facility is suing her former employer in Michigan federal court, claiming she was repeatedly sexually harassed by a kitchen worker, then demoted when she complained to management.

  • June 08, 2026

    Liability Insurer Owes $1M On $13M Botched Surgery Verdict

    A medical professional liability insurer will pay its $1 million policy limit toward a $13 million verdict against a Washington state doctor in a botched cosmetic surgery case, a federal judge has ruled.

  • June 08, 2026

    McKesson Can't Defeat Valid Cost-Sharing Rules, Gov't Says

    The U.S. government urged a Texas federal court to uphold transfer pricing regulations that pharmaceutical giant McKesson is challenging in its push for a nearly $10 million tax refund, arguing the rules fall "well within the bounds" of the underlying statutory text.

  • June 05, 2026

    Colo. Panel Says Medical POA Doesn't Extend To Arbitration

    A medical power of attorney does not let an agent agree to arbitration unless that power is expressly granted, a Colorado appeals panel held, affirming a nursing home's loss in its bid to force arbitration in a negligence and wrongful death suit.

  • June 05, 2026

    NY Judge Recommends Tossing Doctor's Equal Pay Claim

    A New York federal magistrate judge recommended tossing a former cancer physician's federal equal pay claim, finding she failed to show that two higher-paid male physicians performed substantially equal work.

  • June 05, 2026

    Judge Slams Gov't For 'Pretextual' Immigration Filing Pause

    A Rhode Island federal judge ruled on Friday that U.S. Citizenship and Immigration Services' indefinite hold on processing immigration applications for individuals from the 39 countries on President Donald Trump's travel ban list is unlawful.

  • June 04, 2026

    Generics Cos. Get More Freedom In High Court Patent Ruling

    The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid such suits and creates hurdles for branded companies pursuing infringement litigation, attorneys say.

  • June 04, 2026

    Eli Lilly's 'Overbroad' Weight Drug TM Deal Rejected

    A Washington federal judge has refused to sign off on a deal to settle trademark claims brought by Eli Lilly against two Seattle-area medical clinics, saying the associated consent decree was "overbroad" and contained an even more sweeping injunction.

  • June 04, 2026

    Doctor Lied About Risky 'Basket Weave' Surgery, Patients Say

    Six patients accused a Seattle doctor of overstating his "basket weave" surgery technique meant to treat a painful condition known as "slipping rib syndrome," claiming in a Washington state lawsuit that Dr. Madhankumar Kuppusamy failed to disclose the experimental nature of the procedure that left some patients with serious injuries.

  • June 04, 2026

    Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit

    The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharma Inc. had not plausibly alleged that Hikma encouraged healthcare providers to infringe its patents.

  • June 03, 2026

    DOJ Inks $56.5M Deal In Whistleblower Medicare Fraud Suits

    The U.S. Department of Justice said Wednesday that two health assessment companies and a founder of one of them agreed to pay $56.5 million to resolve whistleblower allegations that they submitted false diagnosis information to private Medicare insurers.

Expert Analysis

  • NY Times Word Puzzles Make Me A Better Lawyer

    Author Photo

    Every morning I let The New York Times humble me with word games, which offer a chance to recalibrate my brain before the day's chaos arrives and remind me that a solution — whether to a puzzle or employment law issue — almost always exists once I find the right angle, says Amy Epstein Gluck at Pierson Ferdinand.

  • Law School's Missed Lesson: Diagnose Before Arguing

    Author Photo

    Law school often skips over explicitly teaching students how to determine what kind of problem a case presents before they commit to a particular doctrinal path, which risks building arguments that are internally coherent but externally misaligned, says Melanie Oxhorn at Kobre & Kim.

  • Judges On AI: How Courts Can Survive The Tech Revolution

    Author Photo

    Colorado Supreme Court Justice Maria Berkenkotter and Colorado Court of Appeals Judge Lino Lipinsky de Orlov discuss how artificial intelligence has already fundamentally altered the legal system and offer tips for courts navigating deepfakes, hallucinations and a gap in access to AI tools.

  • 'Skinny Label' Arguments Spotlight Induced Infringement Risk

    Author Photo

    Recent oral arguments before the U.S. Supreme Court in Hikma Pharmaceuticals v. Amarin Pharma highlight the uncertain boundary between lawful generic competition through so-called skinny labels and induced patent infringement, with potential implications for patent holders’ communication, enforcement and causation strategies across industries, says Anton Hopen at Trenam.

  • 3 AI Adoption Mistakes GCs Should Avoid

    Author Photo

    The pressure in-house legal teams face to quickly adopt artificial intelligence tools, combined with budget constraints and the need to evaluate a crowded market of options, sets the stage for implementation mistakes that are often difficult to undo, says former 23andMe general counsel Guy Chayoun.

  • 4 Emerging Approaches To AI Protective Order Language

    Author Photo

    Over the last year, at least five federal district courts have issued or analyzed specific protective order provisions restricting the use of generative artificial intelligence platforms with protected materials, establishing that proactive AI-specific provisions are now standard practice and demonstrating that no single model works for every case, says Joel Bush at Kilpatrick.

  • What Justices Are Focusing On In 'Skinny Label' Patent Case

    Author Photo

    Though Hikma v. Amarin appears to be a patent dispute that could reshape inducement doctrine in the pharmaceutical context, oral argument suggests the U.S. Supreme Court may treat this as primarily a pleading-stage dispute, with important unresolved questions lurking beneath the surface, says Shashank Upadhye at Upadhye Tang.

  • Heppner Ruling Left AI Privilege Risk For Lawyers Unresolved

    Author Photo

    While a New York federal judge’s recent ruling in U.S. v. Heppner resolved a privilege question surrounding client-side artificial intelligence use, it did not address how to mitigate the risks that can arise when confidential information enters the operative context of an AI system used by an attorney, says Jianfei Chen at Quarles & Brady​​​​​​​.

  • Suit's Dismissal Would Not Settle Gold Card Visa's Legality

    Author Photo

    The government’s recent assertion that the plaintiffs in American Association of University Professors v. Department of Homeland Security lack standing to challenge the Trump administration’s pay-to-play immigration program does not address whether an agency can deem a million-dollar gift evidence of eligibility for immigration benefits carefully defined by Congress, says Jun Li at Reid & Wise.

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • What's At Stake For Employers In Fight Over Visa Pause

    Author Photo

    For employers that rely on foreign talent, the Trump administration’s suspension of immigrant visa issuance for the nationals of 75 countries is creating practical problems, and a recently filed lawsuit challenging the pause could determine whether consular processing, for some, ceases to be an individualized process, says attorney Lisa Eisenberg.

  • High Court 'Skinny Label' Case Will Matter To Tech Litigators

    Author Photo

    Hikma v. Amarin, set for oral argument in the U.S. Supreme Court on Wednesday, has potential to affect not just generic drug label-based evidence in patent cases, but also how technology inducement cases are presented and proven, says attorney Abdul Abdullahi.

  • Law School's Missed Lessons: How To Draft Pleadings

    Author Photo

    Most law school graduates step into their first jobs without ever having drafted a complaint, answer, motion or other type of pleading, but that gap can be closed by understanding the strategy embedded in every filing, writing with clarity and purpose, and seeking feedback at every step, says Eric Yakaitis at Haug Barron.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.